CN101987135A - Medicine for treating tetanus and preparation method thereof - Google Patents

Medicine for treating tetanus and preparation method thereof Download PDF

Info

Publication number
CN101987135A
CN101987135A CN2010102649193A CN201010264919A CN101987135A CN 101987135 A CN101987135 A CN 101987135A CN 2010102649193 A CN2010102649193 A CN 2010102649193A CN 201010264919 A CN201010264919 A CN 201010264919A CN 101987135 A CN101987135 A CN 101987135A
Authority
CN
China
Prior art keywords
parts
radix
medicine
citrusaurantiuml
var
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2010102649193A
Other languages
Chinese (zh)
Other versions
CN101987135B (en
Inventor
葛德钜
周兵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010102649193A priority Critical patent/CN101987135B/en
Publication of CN101987135A publication Critical patent/CN101987135A/en
Application granted granted Critical
Publication of CN101987135B publication Critical patent/CN101987135B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine for treating tetanus, which is characterized by being prepared from the following main raw materials in parts by weight: 1-20 parts of rose, 1-20 parts of seville orange flower, 1-20 parts of madder, 1-20 parts of rehmannia root, 1-20 parts of figwort root, 1-20 parts of bark of the peony tree, 1-20 parts of donkey-hide gelatin, 1-20 parts of white paeony root, 1-20 parts of baical skullcap root, 1-20 parts of liquorice and 1-20 parts of edible alcohol with the content above 95 percent. The medicine can be absorbed via the spleen and the stomach through oral administration and via the skin through external use, and can also be absorbed in a combinational way through the oral administration and the external use. The medicine of the invention has the advantages of reasonable formulation, simplified medicine compatibility and definite curative effect and can be used for treating the principal and secondary aspects of a disease. The invention further provides a preparation method of the medicine.

Description

Tetanic medicine of a kind of treatment and preparation method thereof
Technical field
The invention belongs to the field of Chinese medicines, tetanic medicine of treatment of particularly a kind of oral administration or external and preparation method thereof.
Background technology
Tetanus is the longer clostridial infection of a kind of history, a kind of acute specific infection that clostridium tetani intrusion human body wound, growth and breeding, generation toxin can cause.Clostridium tetani and toxin thereof can not be invaded normal skin and mucosa, so after tetanus all occurs in wound.All open injuries all have tetanic possibility take place.
The clinical early symptom of patient is: masticatory spasm, gnathospasma because of histrionic muscles tightens, make face be " risus sardonicus ".Therefore and death by suffocation most patient's Chang Yin muscular spasm outbreaks or tonic convulsion and present opisthotonus, laryngospasm, dyspnea, even.Once inoculate tetanus toxoid in a short time or infected lighter patient, produced the muscular spasm of limitation or miscarriage type, or the tic of local or limbs.The tetanus of head injuries has 3%~4% patient that facial paralysis takes place, with the facial spasm of offside approximately.
Chinese medicine thinks that primary disease is by after the wound, or infection focus is arranged, and loses in medical treatment, and healthy energy is impaired, and the ailment said due to cold or exposure intrusion of taking advantage of a loophole is in the table people, due to the priming liver-wind.
Chinese patent CN200710114846.8 discloses the tetanic Chinese medicine preparation of a kind of treatment, and its prescription is by Pheretima, Periostracum Cicadae, Rhizoma Gastrodiae, Rhizoma Et Radix Notopterygii, Radix Saposhnikoviae, Herba Schizonepetae, Rhizoma Arisaematis, Ramulus Uncariae Cum Uncis, Radix Paeoniae Rubra, Alumen, Radix Ophiopogonis, Cortex Moutan, Poria cum Radix Pini, Scolopendra, Scorpio, Herba Patriniae, Flos Lonicerae, Rhizoma Chuanxiong, Fructus Forsythiae, Flos Carthami, Semen Persicae, when being grouped into.This prescription adopts various materials is ground into powder, sieves, and makes powder.Time spent takes after mixing it with water with cold water, every day 2~3 times.3 days is 1 course of treatment.Chinese patent application CN200710139306.5 discloses the tetanic Chinese medicine preparation of a kind of treatment, and it contains Calculus Bovis, Moschus, Margarita, Olibanum, Myrrha, Borneolum Syntheticum, Radix Notoginseng, Sanguis Draxonis, Zhang Dan, Cinnabaris.
The tetanic Chinese medicine product of above-mentioned treatment is paid attention to regulating too much, and used taste of Chinese medicine number is too much, has reduced the medicine proportion of a therapeutical effect relatively, has influenced the pharmic function performance, so effect is slow, the course of treatment is long, and effect is undesirable.And existing Chinese medicine oral administration but can not external, but can not the taking orally again of external, route of administration is single, makes the patient slow to the absorption of medicine.Chinese medicine for oral administration not only absorbs slowly, and causes spleen injury easily, even increase the weight of the state of an illness for the patient of weakness of the spleen and stomach.
Chinese medicine is taken difficulty owing to mostly be decoction or the pill that boils than Western medicine, has also influenced the popularization of Chinese medicine widely.
Summary of the invention
The objective of the invention is to overcome the defective that prior art exists, a kind of reasonable recipe is provided, compatibility is simplified, the tetanic medicine of treatment of determined curative effect, treating both the principal and secondary aspects of a disease, to control, control foster combination, and this medicine can take orally by taste absorb again can external by skin absorbs, can also oral administration and externally used dual mode composite absorption.This compound administering mode helps the efficient absorption of human body to medicine, and for the crowd of weakness of the spleen and stomach, the medicine that is busy with one's work, spares oneself provides multiple choices, especially the patient by the modern job crowd is accepted.
Technical scheme of the present invention is as follows:
The tetanic medicine of a kind of treatment, it is characterized in that it mainly is to be made by the raw material of following weight portion: 1 ~ 20 part of Flos Rosae Rugosae, 1 ~ 20 part of CitrusaurantiumL.Var.amara Engl., 1 ~ 20 part of Radix Rubiae, 1 ~ 20 part in the Radix Rehmanniae, 1 ~ 20 part of Radix Scrophulariae, 1 ~ 20 part of Cortex Moutan, 1 ~ 20 part in Colla Corii Asini, 1 ~ 20 part of the Radix Paeoniae Alba, 1 ~ 20 part of Radix Scutellariae, 1 ~ 20 part in Radix Glycyrrhizae, 1 ~ 20 part of the edible ethanol of content more than 95%.
Further, the consumption of each component of medicine of the present invention is: 15 ~ 20 parts of Flos Rosae Rugosaes, 15 ~ 20 parts of CitrusaurantiumL.Var.amara Engl.s, 15 ~ 20 parts of Radix Rubiae, 15 ~ 20 parts in the Radix Rehmanniae, 15 ~ 20 parts of Radix Scrophulariaes, 15 ~ 20 parts of Cortex Moutans, 15 ~ 20 parts in Colla Corii Asini, 15 ~ 20 parts of the Radix Paeoniae Albas, 15 ~ 20 parts of Radix Scutellariaes, 15 ~ 20 parts in Radix Glycyrrhizae, 15 ~ 20 parts of the edible ethanol of content more than 95%.
The middle survival dose of above compatibility is the crude drug amount.
In order to strengthen the transdermal effect of medicine, can also mix transdermal agent in the medicine of the present invention, preferably weight portion is 1 ~ 5 part a azone.
Another object of the present invention provides manufacturing method for above mentioned medicine, it is characterized in that comprising the following steps:
A) take by weighing Flos Rosae Rugosae, CitrusaurantiumL.Var.amara Engl., Radix Rubiae, the Radix Rehmanniae, Radix Scrophulariae, Cortex Moutan, Colla Corii Asini, the Radix Paeoniae Alba, Radix Scutellariae and the Radix Glycyrrhizae of described weight proportion, according to the conventional extracting method of Chinese medicine, the extract of the former medicine that obtains respectively respectively to distinguish the flavor of;
B) under the room temperature, get the deionized water of 5 ~ 6 times of amounts, add the edible ethanol of content more than 95% of described weight proportion, be mixed with aqueous solution of alcohol;
C) with in the above-mentioned aqueous solution of alcohol of the extract obtained adding of step a, stirred 120 minutes, precipitate 2 ~ 4 hours, filter, gained filtrate sterilization, fill according to quantity must be treated tetanic medicine.
Further, among the step c, can add in the aqueous solution of alcohol together by azone step a is extract obtained and 1 ~ 5 weight portion.
The conventional extracting method of described Chinese crude drug can adopt decocting method, circumfluence method, infusion process, percolation, semi-bionic extraction, supercritical fluid extraction, microwave extraction method etc. according to the kind of medical material.
Many being taken advantage of a weak point in opponent's defence by exopathogen of tetanus invaded, and leads to pyretic toxicity, the absurd row of forcing blood, and escape of blood from meridians oozes outside arteries and veins, sees due to the skin.
The present invention is directed to tetanic characteristics, select Flos Rosae Rugosae, CitrusaurantiumL.Var.amara Engl., Radix Rubiae, the Radix Rehmanniae, Radix Scrophulariae, Cortex Moutan, Colla Corii Asini, the Radix Paeoniae Alba, Radix Scutellariae, Radix Glycyrrhizae for use,, make to contain pure Chinese medicine extraction liquid being that edible ethanol more than 95% mixes with content after each flavor Chinese medicine extraction.Employing to be to control, and control and support bonded method, but not only also external of oral administration of the medicine of making is a kind of reasonable recipe, and compatibility is simplified, the tetanic medicine of treatment of determined curative effect, treating both the principal and secondary aspects of a disease.
Radix Rubiae nature and flavor hardship, cold, go into the heart; The promoting the circulation of blood hemostasis, dredge the meridian passage, eliminating phlegm and stopping cough.Radix Rehmanniae sweet in the mouth, hardship is slightly cold, GUIXIN, liver, kidney channel; Nourishing YIN and clearing away heat; Removing heat from blood is enriched blood.Radix Scrophulariae nature and flavor hardship is salty, and lung, kidney channel are gone in cold; YIN nourishing, pathogenic fire reducing, relieving restlessness, detoxifcation.The Cortex Moutan nature and flavor are arduous, and the heart, liver, kidney channel are gone in cold; Heat clearing away, removing heat from blood, and blood, repercussive.The Colla Corii Asini nature and flavor are sweet, and are flat, go into lung, liver, kidney channel; With the blood YIN nourishing, remove wind and moisturize, the lung heat clearing of reducing phlegm, diuresis is transferred large intestine.Radix Paeoniae Alba nature and flavor picric acid, liver, spleen channel are gone in cold; Nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing is received antiperspirant.Radix Scutellariae nature and flavor hardship, cold, go into the heart, lung, gallbladder, large intestine channel, the removing the relative excess fire, except that damp and hot, hemostasis.The Radix Glycyrrhizae nature and flavor are sweet, and are flat, go into spleen, stomach, lung meridian; With middle emergency, lung moistening, detoxifcation, coordinating the actions of various ingredients in a prescription.
Reuse the Radix Rehmanniae, Radix Rubiae, Radix Scrophulariae clearing away heat and cooling blood among the present invention; The Radix Paeoniae Alba and battalion's heat clearing away; The Cortex Moutan cool the blood dissipate blood stasis; Radix Scutellariae, Radix Glycyrrhizae clearing away heat,cooling blood and removing toxin; The Colla Corii Asini nourishing YIN and stopping bleeding enriches blood, nourishing the liver and kidney.All medicines cooperate, and play the effect of heat-clearing and toxic substances removing, cooling blood for hemostasis altogether.Radix Scutellariae also has slight blood vessel dilating effect, can alleviate vascular reaction.
Flos Rosae Rugosae regulate the flow of vital energy resolving depression and blood dissipating blood stasis; The CitrusaurantiumL.Var.amara Engl. the chest stuffiness relieving of regulating the flow of vital energy, dispersing the stagnated liver-QI for regulating the stomach, appetizing preventing or arresting vomiting.Two medicines, 5 usefulness, a gas one blood, QI and blood is two transfers, eliminating turbid pathogen with aromatics, the appetizing of being amusing, the strength enhancing that absorbs the drug when oral.The edible ethanol blood circulation promoting and blood stasis dispelling of content more than 95% promotes that drug osmotic to cell absorbs, and auxiliary taste absorb to improve curative effect when oral; Outer time spent skin expansion pore is to strengthen the drug transdermal trap.
Medicine of the present invention can also be smeared the affected part with medicine of the present invention except for oral administration, and the efficacy of a drug sick institute that goes directly so can remove the patient suffering, obtains and imitates in no time.This medicine is applicable to that also whole body smears.Adopt oral administration and externally usedly, drug effect is more remarkable.
It is obvious that the present invention treats the tetanus curative effect, and clinical usefulness repeatly, effect are very prompt.With the clinical verification of medicine of the present invention through clinical 90 routine patients, curing number is 72 examples, and significant figure is 15 examples, and invalid number is 3 examples, and total effective rate reaches 96.7%.Do not see toxic side effect in the therapeutic process.
For further specifying therapeutic effect, it is as follows now to enumerate model case:
Case 1: certain woman 29 years old, because of being subjected to wound future trouble tetanus, local muscle rigidity contraction.Oral medicine of the present invention, each 10 milliliters, every day 3 times, above symptom was alleviated in 1 day, eliminated in 18 days.Paying a return visit after 12 months does not have recurrence.
Case 2: certain man 44 years old, because of being subjected to wound future trouble tetanus, whole-body muscle clonospasm.External medicine of the present invention is smeared whole body and extremity portion, and every day 2 times, each 10 milliliters, repeatedly smear at the extremity place.Above symptom was alleviated in 1 day, eliminated in 13 days.Paying a return visit after 12 months does not have recurrence.
Case 3: certain man 36 years old, because of being subjected to wound future trouble tetanus, gnathospasma, paroxysmal muscular spasm.Oral medicine of the present invention, each 10 milliliters, every day 3 times; This medicine of external is smeared whole body and extremity portion, and every day 2 times, each 10 milliliters, repeatedly smear at the extremity place.Above symptom is oral to be alleviated with external in 1 day, eliminated in 10 days.Paying a return visit after 12 months does not have recurrence.
The specific embodiment
Embodiment 1
Take by weighing 15 parts of Flos Rosae Rugosaes, 18 parts of CitrusaurantiumL.Var.amara Engl.s, 15 parts of Radix Rubiae, 15 parts in the Radix Rehmanniae, 16 parts of Radix Scrophulariaes, 16 parts of Cortex Moutans, 19 parts in Colla Corii Asini, 17 parts of the Radix Paeoniae Albas, 18 parts of Radix Scutellariaes, 20 parts in Radix Glycyrrhizae adopts the method that decocts the back concentrating under reduced pressure to make Chinese medicine extract respectively, and is standby.
Under the room temperature, get the deionized water of 5 ~ 6 times of amounts, add content and be 18 parts of 96% edible ethanols, be mixed with aqueous solution of alcohol, standby.
Above-mentioned various Chinese medicine extract are added in the aqueous solution of alcohol, fully stirred 120 minutes, precipitate 2 ~ 4 hours, supernatant 200 orders filter, and the tetanic medicine of treatment that gained filtrate is oral administration or external carries out fill under aseptic condition.Gained precipitate and filtering residue focus on.
Embodiment 2
The drug component proportioning is: 18 parts of Flos Rosae Rugosaes, and 19 parts of CitrusaurantiumL.Var.amara Engl.s, 19 parts of Radix Rubiae, 19 parts in the Radix Rehmanniae, 18 parts of Radix Scrophulariaes, 18 parts of Cortex Moutans, 20 parts in Colla Corii Asini, 20 parts of the Radix Paeoniae Albas, 19 parts of Radix Scutellariaes, 19 parts in Radix Glycyrrhizae, content is 18 parts of 97% edible ethanols.Other is identical with embodiment 1.
Embodiment 3
The drug component proportioning is: 19 parts of Flos Rosae Rugosaes, and 20 parts of CitrusaurantiumL.Var.amara Engl.s, 20 parts of Radix Rubiae, 20 parts in the Radix Rehmanniae, 19 parts of Radix Scrophulariaes, 19 parts of Cortex Moutans, 20 parts in Colla Corii Asini, 20 parts of the Radix Paeoniae Albas, 19 parts of Radix Scutellariaes, 20 parts in Radix Glycyrrhizae, content is 18 parts of 98% edible ethanols.Other is identical with embodiment 1.
Embodiment 4
The drug component proportioning is: 16 parts of Flos Rosae Rugosaes, and 16 parts of CitrusaurantiumL.Var.amara Engl.s, 17 parts of Radix Rubiae, 17 parts in the Radix Rehmanniae, 16 parts of Radix Scrophulariaes, 15 parts of Cortex Moutans, 17 parts in Colla Corii Asini, 18 parts of the Radix Paeoniae Albas, 16 parts of Radix Scutellariaes, 15 parts in Radix Glycyrrhizae, content is 16 parts of 99% edible ethanols.Other is identical with embodiment 1.
Embodiment 5
The drug component proportioning is: 17 parts of Flos Rosae Rugosaes, and 18 parts of CitrusaurantiumL.Var.amara Engl.s, 16 parts of Radix Rubiae, 18 parts in the Radix Rehmanniae, 19 parts of Radix Scrophulariaes, 18 parts of Cortex Moutans, 17 parts in Colla Corii Asini, 18 parts of the Radix Paeoniae Albas, 18 parts of Radix Scutellariaes, 17 parts in Radix Glycyrrhizae, content is 19 parts of 100% edible ethanols.Other is identical with embodiment 1.
Embodiment 6
The drug component proportioning is: 19 parts of Flos Rosae Rugosaes, and 20 parts of CitrusaurantiumL.Var.amara Engl.s, 19 parts of Radix Rubiae, 18 parts in the Radix Rehmanniae, 20 parts of Radix Scrophulariaes, 20 parts of Cortex Moutans, 19 parts in Colla Corii Asini, 18 parts of the Radix Paeoniae Albas, 20 parts of Radix Scutellariaes, 19 parts in Radix Glycyrrhizae, content is 20 parts of 97% edible ethanols.Other is identical with embodiment 1.

Claims (5)

1. treat tetanic medicine for one kind, it is characterized in that it mainly is to be made by the raw material of following weight portion: 1 ~ 20 part of Flos Rosae Rugosae, 1 ~ 20 part of CitrusaurantiumL.Var.amara Engl., 1 ~ 20 part of Radix Rubiae, 1 ~ 20 part in the Radix Rehmanniae, 1 ~ 20 part of Radix Scrophulariae, 1 ~ 20 part of Cortex Moutan, 1 ~ 20 part in Colla Corii Asini, 1 ~ 20 part of the Radix Paeoniae Alba, 1 ~ 20 part of Radix Scutellariae, 1 ~ 20 part in Radix Glycyrrhizae, 1 ~ 20 part of the edible ethanol of content more than 95%.
2. medicine as claimed in claim 1, it is characterized in that it mainly is to be made by the raw material of following weight portion: 15 ~ 20 parts of Flos Rosae Rugosaes, 15 ~ 20 parts of CitrusaurantiumL.Var.amara Engl.s, 15 ~ 20 parts of Radix Rubiae, 15 ~ 20 parts in the Radix Rehmanniae, 15 ~ 20 parts of Radix Scrophulariaes, 15 ~ 20 parts of Cortex Moutans, 15 ~ 20 parts in Colla Corii Asini, 15 ~ 20 parts of the Radix Paeoniae Albas, 15 ~ 20 parts of Radix Scutellariaes, 15 ~ 20 parts in Radix Glycyrrhizae, 15 ~ 20 parts of the edible ethanol of content more than 95%.
3. medicine as claimed in claim 1 or 2 is characterized in that described medicine comprises that also weight portion is 1 ~ 5 part a azone.
4. the preparation method of the described medicine of one of claim 1 to 3 is characterized in that comprising the following steps:
A) take by weighing Flos Rosae Rugosae, CitrusaurantiumL.Var.amara Engl., Radix Rubiae, the Radix Rehmanniae, Radix Scrophulariae, Cortex Moutan, Colla Corii Asini, the Radix Paeoniae Alba, Radix Scutellariae and the Radix Glycyrrhizae of described weight proportion, according to the conventional extracting method of Chinese medicine, the extract of the former medicine that obtains respectively respectively to distinguish the flavor of;
B) under the room temperature, get the deionized water of 5 ~ 6 times of amounts, add the edible ethanol of content more than 95% of described weight proportion, be mixed with aqueous solution of alcohol;
C) with in the above-mentioned aqueous solution of alcohol of the extract obtained adding of step a, stirred 120 minutes, precipitate 2 ~ 4 hours, filter, gained filtrate sterilization, fill according to quantity must be treated tetanic medicine.
5. preparation method as claimed in claim 4 is characterized in that, among the step c, azone step a is extract obtained and described weight proportion adds aqueous solution of alcohol together.
CN2010102649193A 2010-08-27 2010-08-27 Medicine for treating tetanus and preparation method thereof Expired - Fee Related CN101987135B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010102649193A CN101987135B (en) 2010-08-27 2010-08-27 Medicine for treating tetanus and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010102649193A CN101987135B (en) 2010-08-27 2010-08-27 Medicine for treating tetanus and preparation method thereof

Publications (2)

Publication Number Publication Date
CN101987135A true CN101987135A (en) 2011-03-23
CN101987135B CN101987135B (en) 2012-07-25

Family

ID=43744054

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010102649193A Expired - Fee Related CN101987135B (en) 2010-08-27 2010-08-27 Medicine for treating tetanus and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101987135B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103784795A (en) * 2014-01-21 2014-05-14 李慧 Traditional Chinese medicine for treating tetanus
CN105521025A (en) * 2014-11-05 2016-04-27 李进凯 Traditional Chinese medicine for treating spasm of pharyngeal muscle

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103816426B (en) * 2014-03-14 2016-06-08 邢立志 A kind of pathogenic wind toxic for the treatment of enters the Chinese medicine of interior syndrome's type Tetanus

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1175444A (en) * 1997-07-10 1998-03-11 迟经惠 Detoxicatio pill for tetanus
CN101152460A (en) * 2007-09-18 2008-04-02 尹克山 Traditional Chinese medicine for treating postpartum tetanus
CN101181534A (en) * 2007-12-04 2008-05-21 朱惠芬 Traditional Chinese medicine preparation for curing tetanus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1175444A (en) * 1997-07-10 1998-03-11 迟经惠 Detoxicatio pill for tetanus
CN101152460A (en) * 2007-09-18 2008-04-02 尹克山 Traditional Chinese medicine for treating postpartum tetanus
CN101181534A (en) * 2007-12-04 2008-05-21 朱惠芬 Traditional Chinese medicine preparation for curing tetanus

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
《中兽医医药杂志》 20061231 戴永海,等 中兽医对传染病的认识与防治 64-66 1 , 第6期 *
《中国中医秘方大全》 19891031 胡熙明 茜草汤 文汇出版社 391 1 , *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103784795A (en) * 2014-01-21 2014-05-14 李慧 Traditional Chinese medicine for treating tetanus
CN105521025A (en) * 2014-11-05 2016-04-27 李进凯 Traditional Chinese medicine for treating spasm of pharyngeal muscle

Also Published As

Publication number Publication date
CN101987135B (en) 2012-07-25

Similar Documents

Publication Publication Date Title
CN103316146B (en) Traditional Chinese medicinal preparation for anesthesia
CN101972446B (en) Medicament for treating coronary disease and preparation method thereof
CN101987166B (en) Medicament for treating stye and preparation method thereof
CN101987135B (en) Medicine for treating tetanus and preparation method thereof
CN106806877A (en) Improve dysmenorrhoea Chinese medicine composition and preparation method thereof and drinks
CN102626478A (en) Externally used Chinese herbal medicine compound for treating lumbar muscle strain for years
CN105343660A (en) Traditional Chinese medicinal preparation for treating peripheral vertigo and preparation method of traditional Chinese medicinal preparation
CN101987132B (en) Medicament for treating acne and preparation method thereof
CN101912596A (en) Medicament for treating allergic rhinitis and preparation method thereof
CN101912498B (en) Medicament for treating gout and preparation method thereof
CN108261506B (en) Medicine for treating alopecia
CN101987159B (en) Medicine for treating erysipelas and preparation method thereof
CN105106634A (en) Traditional Chinese medicine preparation for treating acute appendicitis and application thereof
CN104998158A (en) Pharmaceutical composition for treating liver cirrhosis and application thereof
CN101904962B (en) Medicament for treating cold and preparation method thereof
CN107335034A (en) A kind of external medicine composition for treating leucoderma and its application
CN111388604B (en) Traditional Chinese medicine composition for treating migraine and preparation method thereof
CN105194337A (en) Medicine for treating idiopathic tubulointerstitial nephritis
CN101085312A (en) Traditional Chinese medicine for treating hyperdyroidism
CN105998738A (en) Traditional Chinese medicinal composition for treating night sweat
CN105709176A (en) Traditional Chinese medicine composition for treating heart blood stasis type palpitation and preparation method thereof
CN104524149A (en) Pharmaceutical composition for preventing and treating acute nephritis and application thereof
CN104873854A (en) Traditional Chinese medicine preparation for rteriolar nephrosclerosis and preparation method thereof
CN101983653B (en) Drug for treating lumbocrural pain and preparation method thereof
CN102886020A (en) Chinese medicinal composition for treating epilepsy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120725

Termination date: 20180827